1. Abelous JE, Bardier E. Les substances hypotensives de l’urine humaine normale. CR Soc Biol. 1909;66:511–20.
2. Azizi M, Boutouyrie P, Bissery A, Agharazii M, Verbeke F, Stern N, et al. Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. J Clin Invest. 2005 Mar;115(3):780–7.
3. Azizi M, Emanueli C, Peyrard S, Maddedu P, Alhenc-Gelas F, Campbell DJ. Genetic and dietary control of plasma tissue kallikrein secretion and urinary kinins excretion in man. J Hypertens. 2008 Apr;26(4):714–20.
4. Bergaya S, Meneton P, Bloch-Faure M, Mathieu E, Alhenc-Gelas F, Levy B, Boulanger C. Decreased flow-dependent dilatation in carotid arteries of tissue kallikrein-knockout mice. Circ Res. 2001;88(6):593–9.
5. Berry TD, Hasstedt SJ, Hunt SC, Wu LL, Smith JB, Ash KO, et al. A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension. 1989 Jan;13(1):3–8.